Epidemiology and microbiological features of anaerobic bacteremia in two French University hospitals

• Published in: Anaerobe Vol. 64; p. 102207
• Main Authors: Dumont, Yann, Bonzon, Lucas, Michon, Anne-Laure, Carriere, Christian, Didelot, Marie-Noëlle, Laurens, Chrislène, Renard, Beatrice, Veloo, Alida C.M., Godreuil, Sylvain, Jean-Pierre, Hélène
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01-08-2020; Elsevier Masson
• Subjects: Life Sciences
• ISSN: 1075-9964; 1095-8274
• DOI: 10.1016/j.anaerobe.2020.102207

Bacteremia implicating anaerobic bacteria (BIAB) represents 2–6% of all episodes of bacteremia and is associated with high mortality. In this retrospective study from June 2015 to December 2016, we compared BIAB frequency in two hospital centers in Montpellier (France): Montpellier university hospital (MUH) and a center specialized in cancer (ICM). Among the 2465 microbiologically relevant episodes of bacteremia, we identified 144 (5.8%) in which anaerobic bacteria were implicated. BIAB frequency was higher at ICM than MUH (10.4%, vs. 4.9%, p < 0.01). Poly-microbial bacteremia was more frequent among the BIAB episodes (31.9% vs. 11.0% for aerobic-only bacteremia, p < 0.01). Bacteroides and Clostridium were the most frequently identified genera of anaerobic bacteria (64 and 18 episodes, respectively), with the B. fragilis group (BFG) involved in 68/144 episodes. We could perform antibiotic susceptibility typing in 106 of the 144 anaerobic isolates, including 67 BFG isolates. All isolates but one were susceptible to metronidazole. In the BFG, sporadic resistant or intermediate results were found for amoxicillin-clavulanate (5/67), piperacillin-tazobactam (2/67) and imipenem (1/67). BFG isolates were susceptible also to cefoxitin (90.8%), rifampicin (97.0%) and tigecyclin (91.0%). Multidrug resistance in this group (7 isolates) was mostly due to acquired resistance to moxifloxacin, clindamycin and tigecyclin. This study shows that BIAB frequency can vary among hospitals and services. They should especially be taken into account in centers specialized in cancer treatment. However, the implicated bacteria remain frequently susceptible to the most used antibiotics used against anaerobic bacteria, although resistance does exist.
•Frequency of anaerobic bacteria in bacteremia differed among centers.•One out of 10 bacteremia in a cancer treatment center involved anaerobic bacteria.•Bacteroides fragilis group was implicated in almost half of these cases.•Resistance to antibiotics was frequent to clindamycin and fluoroquinolones.•Resistance against the most used antimicrobials against anaerobes does exist.